The price of this share is at 0,42$, Sio Gene Therapies Inc, with address at 130 WEST 42ND STREET 26TH FLOOR, NEW YORK, New York, 10036, United States, is a publicly traded company and its visible heads at the moment are David W. Nassif (CFO, Chief Accounting Officer & General Counsel), Gavin R. Corcoran (Chief Research & Development Officer), Parag V. Meswani (Senior VP-Commercial Strategy & Operations), Pavan Cheruvu (Chief Executive Officer & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 0,41$ - 0,44$, with a percentage difference of 0,42$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
